Status:
COMPLETED
The Impact of Simulated Forest Immersion Therapy on Pain and Anxiety in Patients Axial Spondyloarthritis (axSpA)
Lead Sponsor:
Oregon Health and Science University
Conditions:
Axial Spondyloarthritis
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
The purpose of the study is to learn about the ease of using a humidified fragrant citrus forest oil, along with a virtual simulation of a forest environment (i.e., with sights and sounds of nature us...
Detailed Description
DURATION: Participation in the study will consist of 1 visit total and will last up to 2 consecutive hours. PROCEDURES: Participants will be randomized to receive either the forest oils only, or th...
Eligibility Criteria
Inclusion
- able to read at a 5th grad level
- medically diagnosed with Axial Spondyloarthritis
- tolerate having their BP and HR taken
- average of greater than 3 on their last recorded pain assessments
- average of greater than 4 on their last BASDI recorded
- currently have an assigned Rheumatologist in their care delivery
Exclusion
- history of asthma
- currently pregnant
- inability to detect common odors from commercial fragrances
- smoking within 15 minutes of the start of the intervention procedure
- known allergy to citrus aroma
- hard of hearing without assistive devices
- limited vision not corrected by eye lenses
- history of hypertension uncontrolled by medications
Key Trial Info
Start Date :
September 21 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06072859
Start Date
September 21 2023
End Date
March 31 2024
Last Update
July 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health & Science University
Portland, Oregon, United States, 97239